K.J. Harrison & Partners Inc Invests $1.86 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

K.J. Harrison & Partners Inc bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 20,812 shares of the exchange traded fund’s stock, valued at approximately $1,858,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XBI. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $102,900,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in SPDR S&P Biotech ETF by 103.3% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after purchasing an additional 900,000 shares during the period. Employees Retirement System of Texas acquired a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $27,456,000. MBB Public Markets I LLC raised its position in SPDR S&P Biotech ETF by 67.0% in the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after purchasing an additional 206,337 shares during the period. Finally, abrdn plc purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $14,436,000.

SPDR S&P Biotech ETF Stock Up 1.5 %

Shares of NYSEARCA XBI traded up $1.27 on Friday, hitting $83.49. The company had a trading volume of 10,390,133 shares, compared to its average volume of 11,723,970. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The firm has a market capitalization of $6.49 billion, a P/E ratio of 11.47 and a beta of 1.08. The business has a 50 day moving average of $92.69 and a two-hundred day moving average of $84.64.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.